COVID-19 is transmitted through droplets, however, using nebulisers has the potential to create ‘aerosolised’ virus particles. As cases of COVID-19 and suspected COVID-19 increase within Monash Health, the risk of ‘aerosolising’ viral particles increases.
Prescribers should use alternatives to nebulisers such as a different route or an alternate medication. For example, replace 5mg nebulised salbutamol with 12 puffs (100mcg per puff) of salbutamol via metered dose inhaler (MDI) and spacer.
An alert will now appear on the EMR when prescribing a nebulised medication, which will indicate that the patient must be discussed with a Medical Consultant.
If nebulisation is absolutely required then N95 masks should be used for employees caring for COVID-19 and suspected COVID-19 patients.
The patient should be managed in a single room or a negative pressure room if available. Using a nebuliser in a multi-bed room is strongly discouraged.